Arabic Arabic English English French French German German
dark

IR-Med to Announce 2022 Goals: Anticipated POC Results, File for FDA Clearance and up Listing to the OTCQB

IR-Med (OTC: IRME) (“Company” or “the Company”) is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Gracell Biotechnologies Unveils Innovation Center in U.S.

Next Post

AlzeCure Holds a Digital Capital Markets Day on 18 January

Related Posts
Total
0
Share